区分后颅窝室管膜瘤亚组的影像学特征
本研究比较了后颅窝室管膜瘤A组(EPN_PFA)与B组(EPN_PFB)的术前MRI特征,由三名独立阅片者盲法回顾两个中心68例患者的影像,比较位置、范围、体积、脑积水、钙化、组织成分、强化及扩散信号等。结果显示两组在肿瘤体积、脑积水程度、第四脑室中央位置比例、钙化、后颅窝孔道侵犯、强化模式及囊性成分方面存在差异,形态学特征可能有助于术前区分亚型。
要点
- EPN_PFA多为第四脑室中央或偏侧的组织样钙化肿块,强化不完全,常见于幼儿,伴明显脑积水和后颅窝孔道侵犯。
- EPN_PFB多为青少年及成人的中央非钙化肿块,以囊性为主,侵袭性小,呈完全均匀强化。
- 肿瘤内钙化在EPN_PFA占93%、EPN_PFB占40%,完全均匀强化在EPN_PFA占5%、EPN_PFB占75%。
核心结论
- 影像形态学特征在后颅窝室管膜瘤亚型间存在差异,可能有助于术前区分EPN_PFA与EPN_PFB。
- 作者认为该研究提供了区分A组与B组室管膜瘤的工具,最终有望在患者管理早期调整治疗策略。
研究设计与样本
- 研究类型为两中心影像回顾性比较研究,术前影像由三名独立阅片者盲法评估组织分子分组。
- 共纳入68例后颅窝室管膜瘤患者,其中56例为EPN_PFA、12例为EPN_PFB。
- 比较内容包括位置、肿瘤延伸、肿瘤体积、脑积水、钙化、组织成分、强化或扩散信号,以及组织病理学数据(细胞密度、钙化、坏死、核分裂、血管化和微血管增生)。
- 分类数据采用Fisher精确检验,定量数据采用Mann-Whitney检验,并对p值进行Benjamini-Hochberg校正以处理多重检验。
关键影像表现/征象
- EPN_PFA中位肿瘤体积大于EPN_PFB(57 vs 29 cm³,p=0.003),脑积水更明显(p=0.002)。
- EPN_PFA中61%患者肿瘤完全位于第四脑室中央,EPN_PFB为92%(p=0.01)。
- 肿瘤内钙化见于93%的EPN_PFA和40%的EPN_PFB(p=0.001)。
- 后颅窝孔道侵犯主要见于EPN_PFA,尤其是Luschka孔(p=0.0008)。
- EPN_PFA中完全均匀强化占5%,EPN_PFB占75%(p=0.0008);所有以囊性为主的肿瘤均为EPN_PFB(p=0.002)。
诊断标准与关键数值
- EPN_PFA与EPN_PFB的中位年龄分别为2岁和20岁(p=0.0008)。
- EPN_PFA最小和最大相对ADC值略低于EPN_PFB(分别为p=0.02和p=0.01)。
临床应用与阅片要点
- 阅片时注意肿瘤是否完全位于第四脑室中央、有无肿瘤内钙化、后颅窝孔道(尤其Luschka孔)侵犯、强化是否完全均匀以及是否以囊性为主,这些特征有助于术前提示EPN_PFA或EPN_PFB。
- EPN_PFA多见于幼儿,常伴较大肿瘤体积和明显脑积水;EPN_PFB多见于青少年及成人,以囊性为主且强化完全均匀。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Posterior fossa ependymoma group A (EPN_PFA) and group B (EPN_PFB) can be distinguished by their DNA methylation and give rise to different prognoses. We compared the MRI characteristics of EPN_PFA and EPN_PFB at presentation.
METHODS: Preoperative imaging of 68 patients with posterior fossa ependymoma from two centers was reviewed by three independent readers, blinded for histomolecular grouping. Location, tumor extension, tumor volume, hydrocephalus, calcifications, tissue component, enhancement or diffusion signal, and histopathological data (cellular density, calcifications, necrosis, mitoses, vascularization, and microvascular proliferation) were compared between the groups. Categorical data were compared between groups using Fisher's exact tests, and quantitative data using Mann-Whitney tests. We performed a Benjamini-Hochberg correction of the p values to account for multiple tests.
RESULTS: Fifty-six patients were categorized as EPN_PFA and 12 as EPN_PFB, with median ages of 2 and 20 years, respectively (p = 0.0008). The median EPN_PFA tumoral volume was larger (57 vs 29 cm3, p = 0.003), with more pronounced hydrocephalus (p = 0.002). EPN_PFA showed an exclusive central position within the 4th ventricle in 61% of patients vs 92% for EPN_PFB (p = 0.01). Intratumor calcifications were found in 93% of EPN_PFA vs 40% of EPN_PFB (p = 0.001). Invasion of the posterior fossa foramina was mostly found for EPN_PFA, particularly the foramina of Luschka (p = 0.0008). EPN_PFA showed whole and homogeneous tumor enhancement in 5% vs 75% of EPN_PFB (p = 0.0008). All mainly cystic tumors were EPN_PFB (p = 0.002). The minimal and maximal relative ADC was slightly lower in EPN_PFA (p = 0.02 and p = 0.01, respectively).
CONCLUSION: Morphological characteristics from imaging differ between posterior fossa ependymoma subtypes and may help to distinguish them preoperatively.
CLINICAL RELEVANCE STATEMENT: This study provides a tool to differentiate between group A and group B ependymomas, which will ultimately allow the therapeutic strategy to be adapted in the early stages of patient management.
KEY POINTS: • Posterior fossa ependymoma subtypes often have different imaging characteristics. • Posterior fossa ependymomas group A are commonly median or lateral tissular calcified masses, with incomplete enhancement, affecting young children and responsible for pronounced hydrocephalus and invasion of the posterior fossa foramina. • Posterior fossa ependymomas group B are commonly median non-calcified masses of adolescents and adults, predominantly cystic, and minimally invasive, with total and homogeneous enhancement.
引用
- Leclerc T, Levy R, Tauziède-Espariat A, et al. Imaging features to distinguish posterior fossa ependymoma subgroups. Eur Radiol. 2023. PMID: 37658900. doi:10.1007/s00330-023-10182-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。